Zealand Pharma A/S (OTCMKTS:ZLDPF) Stock Price Up 8% – Time to Buy?

Zealand Pharma A/S (OTCMKTS:ZLDPF) shares rose 8% during trading on Thursday . The company traded as high as $114.49 and last traded at $114.49. Approximately 337 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 1,958 shares. The stock had previously closed at $106.00.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. began coverage on Zealand Pharma A/S in a research note on Friday, November 8th. They issued an “overweight” rating for the company.

Zealand Pharma A/S Stock Performance

The company has a current ratio of 35.49, a quick ratio of 35.49 and a debt-to-equity ratio of 0.03. The business’s 50-day simple moving average is $112.05 and its 200-day simple moving average is $118.56.

Zealand Pharma A/S Company Profile

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon.